Jason J. Luke, Ardy Davarifar, Yana G. Najjar, Omid Hamid, Dirk Schadendorf, Michael K.K. Wong, Nikhil I. Khushalani, Paolo Antonio Ascierto, Tawnya Lynn Bowles, Mark Navarro, Giuseppe Gullo, Caroline Robert. "A randomized, controlled, multicenter, phase 3 study of vusolimogene oderparepvec combined with nivolumab vs treatment of physician’s choice in patients with advanced melanoma that has progressed on anti–PD-1 and anti–CTLA-4 therapy (IGNYTE-3).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps9599